DABIGATRAN

作品数:34被引量:42H指数:4
导出分析报告
相关领域:医药卫生更多>>
相关机构:北京大学中国药科大学更多>>
相关期刊:《World Journal of Clinical Cases》《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》《Journal of Geriatric Cardiology》《Chinese Journal of Traumatology》更多>>
相关基金:国家重点基础研究发展计划更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 期刊=World Journal of Cardiologyx
条 记 录,以下是1-3
视图:
排序:
Dabigatran in cardiovascular disease management:A comprehensive review被引量:1
《World Journal of Cardiology》2021年第12期710-719,共10页Ayesha Javed Muhammad Ajmal Aaron Wolfson 
Dabigatran,a direct thrombin inhibitor,has robust data for the treatment of deep venous thrombosis and pulmonary embolism,stroke prevention in non-valvular atrial fibrillation,and the prophylaxis of venous thromboembo...
关键词:DABIGATRAN ANTICOAGULATION THROMBUS BLEEDING Atrial fibrillation Deep venous thrombosis Stroke 
Dabigatran,rivaroxaban,and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation:An updated metaanalysis被引量:5
《World Journal of Cardiology》2021年第4期82-94,共13页Wei-Jia Li Paraschos Archontakis-Barakakis Leonidas Palaiodimos Dimitrios Kalaitzoglou Lazaros Tzelves Apostolos Manolopoulos Yu-Chiang Wang Stefanos Giannopoulos Robert Faillace Damianos G Kokkinidis 
BACKGROUND Most of the randomized clinical trials that led to the wide use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation(AF)originated from western countrie...
关键词:Novel oral anticoagulant Direct oral anticoagulant Atrial fibrillation Asian population DABIGATRAN RIVAROXABAN APIXABAN WARFARIN 
Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy被引量:3
《World Journal of Cardiology》2011年第11期351-358,共8页Andrea Rubboli Cecilia Becattini Freek WA Verheugt 
Bleeding is the most important complication of oral anticoagulation (OAC) with vitamin K-antagonists. Whilst bleeding is unavoidably related to OAC, it may have a great impact on the prognosis of treated subjects by l...
关键词:Bleeding Oral ANTICOAGULATION VITAMIN K ANTAGONISTS DABIGATRAN APIXABAN RIVAROXABAN 
检索报告 对象比较 聚类工具 使用帮助 返回顶部